SC
XBI icon

Scotia Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Scotia Capital’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.88M Buy
38,224
+1,006
+3% +$126K 0.02% 298
2025
Q4 		$4.54M Sell
37,218
-194
-0.5% -$22.2K 0.02% 316
2025
Q3 		$3.75M Sell
37,412
-1,557
-4% -$140K 0.02% 341
2025
Q2 		$3.23M Buy
38,969
+1,450
+4% +$116K 0.02% 355
2025
Q1 		$3.04M Sell
37,519
-25,055
-40% -$2.24M 0.02% 343
2024
Q4 		$5.64M Buy
62,574
+7,396
+13% +$717K 0.03% 247
2024
Q3 		$5.45M Sell
55,178
-1,947
-3% -$191K 0.03% 248
2024
Q2 		$5.3M Buy
57,125
+1,738
+3% +$156K 0.03% 244
2024
Q1 		$5.26M Buy
55,387
+1,970
+4% +$183K 0.03% 246
2023
Q4 		$4.77M Buy
53,417
+12,280
+30% +$912K 0.03% 248
2023
Q3 		$3M Buy
41,137
+1,933
+5% +$154K 0.02% 290
2023
Q2 		$3.26M Sell
39,204
-530
-1% -$44.3K 0.02% 283
2023
Q1 		$3.03M Buy
39,734
+446
+1% +$37K 0.02% 291
2022
Q4 		$3.26M Sell
39,288
-1,509
-4% -$122K 0.03% 282
2022
Q3 		$3.24M Sell
40,797
-856
-2% -$72.2K 0.03% 270
2022
Q2 		$3.09M Buy
41,653
+2,479
+6% +$186K 0.02% 294
2022
Q1 		$3.52M Buy
39,174
+21,570
+123% +$1.99M 0.02% 315
2021
Q4 		$1.97M Buy
17,604
+437
+3% +$52.7K 0.01% 409
2021
Q3 		$2.16M Buy
17,167
+1,312
+8% +$169K 0.02% 383
2021
Q2 		$2.15M Buy
15,855
+813
+5% +$107K 0.02% 378
2021
Q1 		$2.04M Buy
15,042
+324
+2% +$48.5K 0.02% 355
2020
Q4 		$2.07M Sell
14,718
-359
-2% -$46K 0.02% 323
2020
Q3 		$1.68M Sell
15,077
-1,551
-9% -$174K 0.02% 319
2020
Q2 		$1.88M Buy
16,628
+284
+2% +$28K 0.03% 269
2020
Q1 		$1.27M Buy
16,344
+121
+0.7% +$10.7K 0.02% 301
2019
Q4 		$1.54M Sell
16,223
-184
-1% -$15.9K 0.02% 326
2019
Q3 		$1.25M Sell
16,407
-1,235
-7% -$103K 0.01% 354
2019
Q2 		$1.55M Sell
17,642
-737
-4% -$62.9K 0.02% 329
2019
Q1 		$1.66M Sell
18,379
-391
-2% -$33.3K 0.02% 305
2018
Q4 		$1.35M Sell
18,770
-4,411
-19% -$355K 0.02% 317
2018
Q3 		$2.22M Sell
23,181
-11,626
-33% -$1.13M 0.03% 277
2018
Q2 		$3.04M Buy
34,807
+750
+2% +$68.9K 0.04% 220
2018
Q1 		$2.99M Sell
34,057
-2,170
-6% -$198K 0.04% 230
2017
Q4 		$3.08M Sell
36,227
-978
-3% -$81.9K 0.04% 228
2017
Q3 		$3.22M Buy
37,205
+1,541
+4% +$124K 0.05% 216
2017
Q2 		$2.75M Sell
35,664
-1,379
-4% -$97.8K 0.05% 214
2017
Q1 		$2.57M Sell
37,043
-5,881
-14% -$395K 0.04% 231
2016
Q4 		$2.54M Buy
+42,924
New +$2.65M 0.04% 257

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Scotia Capital's XBI Position: Q1 2026 in Review

Scotia Capital increased its State Street SPDR S&P Biotech ETF (XBI) stake by 2.7% in Q1 2026, buying an estimated $126K and bringing the position to 38,224 shares worth $4.88M. The position accounts for 0.02% of the portfolio, ranked #298.

Scotia Capital first reported a position in XBI in Q4 2016 and has held it in 38 quarters since. The position peaked at $5.64M in Q4 2024. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Scotia Capital held 38,224 shares of State Street SPDR S&P Biotech ETF worth $4.88M as of Q1 2026.
  • Scotia Capital bought 1,006 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $126K.
  • State Street SPDR S&P Biotech ETF made up 0.02% of Scotia Capital's portfolio in Q1 2026, its #298 holding.
  • Scotia Capital first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and has held it in 38 quarters since.
  • Scotia Capital's State Street SPDR S&P Biotech ETF position peaked at $5.64M in Q4 2024.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.